Summary by Moomoo AI
Aclarion, Inc., a healthcare technology company, reported financial results for the quarter ended September 30, 2024. Revenue for the quarter was $14,407, a decrease from $19,065 in the same period last year. The company experienced a gross loss of $6,925 compared to a gross loss of $493 in the previous year, primarily due to the conclusion of certain clinical activities. Operating expenses totaled $1,289,033, with sales and marketing expenses increasing by 21% to $232,775, and general and administrative expenses rising by 12% to $860,461. Research and development expenses slightly decreased to $195,797. The net loss for the quarter was $1,366,176, deepening from a net loss of $998,010 in the prior year. The company also accrued dividends for preferred stockholders amounting to $12,142. Aclarion's cash position, including restricted cash, was $1,322,098 as of September 30, 2024. The company...Show More